Structural basis for the action of the drug trametinib at KSR-bound MEKZ.M. Khan, Arvin C. Dar, Mary E. Duffy et al.|Nature|2020Cited by 172
Live-cell target engagement of allosteric MEKi on MEK–RAF/KSR–14-3-3 complexesWilliam M. Marsiglia, Arvin C. Dar, He Liu et al.|Nature Chemical Biology|2023Cited by 5
Conformational control and regulation of the pseudokinase KSR via small molecule binding interactionsArthur Chow, Arvin C. Dar, Z.M. Khan et al.|Methods in enzymology on CD-ROM/Methods in enzymology|2022Cited by 2
Structural Insights into How Protein-Protein Interaction Modulates the Action of MEK InhibitorsZ.M. Khan, Arvin C. Dar, William M. Marsiglia et al.|Microscopy and Microanalysis|2021Cited by 0
An Antagonist of KSR1‐Driven Adaptive Resistance to Clinical RAS‐MAPK InhibitorsArthur Chow, Arvin C. Dar, Kyna Reyes et al.|The FASEB Journal|2022Cited by 0